glp-1 agonists in development GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction Frontiers | GLP-1 receptor agonists:

Since BPC-157 isn't regulated as a drug, quality varies widely between sources

Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, ONeil J, et al

Side Effects Side Effects B12 injections common B12 injections common Injection site pain, redness, or mild swelling Mild nausea immediately after injection Headache in some patients B12 injections rare but important B12 injections rare but important including anaphylaxis in rare cases, particularly with hydroxocobalamin

Gray-market peptides can create risks beyond the peptide itself, raising concerns over product quality, purity, and inconsistent formulation